學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Penicillin: The Miracle Drug
內容大綱
This case is a study of the initial discovery of penicillin and how it came to be a mass-market product. The discovery of penicillin is fascinating first and foremost because of its direct, life-saving benefits and because of the context of World War II that surrounded its rise. Throughout the case, an argument is made for the importance of this invention not only for the society of the 1940s, but for our society today. Students are introduced to a handful of the individuals and institutions involved in the discovery and development of the technology, providing them with the information necessary to consider the people, institutions, and other factors that led to the drug's success. Students consider especially the role of intellectual property during penicillin's rise to success, as well as the cultural and legal differences between Britain and the United States related to the patenting of medical discoveries.